
There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.

William Alegria, PharmD, BCIDP is an infectious diseases clinical pharmacist and antimicrobial stewardship consultant with the Stanford Antimicrobial Safety and Sustainability Program. He is a lecturer in the Division of Infectious Diseases and Geographic Medicine at Stanford University School of Medicine. In his role as a member of the antimicrobial stewardship program, Alegria focuses on optimizing antimicrobial use in immunocompromised patients.

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.